Comparative effect of dihydroartemisinin-piperaquine and artemether-lumefantrine on gametocyte clearance and haemoglobin recovery in children with uncomplicated Plasmodium falciparum malaria in Africa: a systematic review and meta-analysis of randomized control trials

被引:3
|
作者
Assefa, Dawit Getachew [1 ,2 ]
Yismaw, Gizachew [1 ]
Makonnen, Eyasu [1 ,3 ]
机构
[1] Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa, Addis Ababa 9087, Ethiopia
[2] Dilla Univ, Coll Hlth Sci & Med, Dept Nursing, Dilla, Ethiopia
[3] Addis Ababa Univ, Coll Hlth Sci, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia
关键词
Dihydroartemisinin-piperaquine; Artemether-lumefantrine; Systematic review and meta-analysis; Africa; RISK-FACTORS; COMBINATION TREATMENTS; CARRIAGE; TRANSMISSION; ANEMIA; EFFICACY;
D O I
10.1016/j.ijid.2021.10.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Plasmodium falciparum gametocytaemia has been associated with anaemia. The aim of this review was to synthesize available evidence on the comparative effect of dihydroartemisinin-piperaquine (DHA-PQ) and artemether-lumefantrine (AL) on gametocyte clearance and haemoglobin recovery in chil-dren with uncomplicated P. falciparum malaria in Africa. Methods: A systematic literature search was undertaken to identify relevant articles from online databases. The search was performed from August 2020 to 30 April 2021. Extracted data from eligible studies were pooled as risk ratios with 95% confidence intervals (CI). Results: Gametocyte carriage was reduced in both treatment groups, with no significant difference found between the groups. However, on days 28 and 42, a significant increase in serum haemoglobin level from baseline was observed in the DHA-PQ group (standardized mean difference 0.15, 95% CI 0.05-0.26; participants = 2715; studies = 4; I 2 = 32%, high quality of evidence) compared with the AL group (mean dif-ference 0.35, 95% CI 0.12-0.59; participants = 1434; studies = 3; I 2 = 35%, high quality of evidence). Conclusion: DHA-PQ had a greater impact on haemoglobin recovery than AL on days 28 and 42; this difference was significant. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:136 / 147
页数:12
相关论文
共 50 条
  • [41] The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
    Commons, Robert J.
    Simpson, Julie A.
    Thriemer, Kamala
    Abreha, Tesfay
    Adam, Ishag
    Anstey, Nicholas M.
    Assefa, Ashenafi
    Awab, Ghulam R.
    Baird, J. Kevin
    Barber, Bridget E.
    Chu, Cindy S.
    Dahal, Prabin
    Daher, Andre
    Davis, Timothy M. E.
    Dondorp, Arjen M.
    Grigg, Matthew J.
    Humphreys, Georgina S.
    Hwang, Jimee
    Karunajeewa, Harin
    Laman, Moses
    Lidia, Kartini
    Moore, Brioni R.
    Mueller, Ivo
    Nosten, Francois
    Pasaribu, Ayodhia P.
    Pereira, Dhelio B.
    Phyo, Aung P.
    Poespoprodjo, Jeanne R.
    Sibley, Carol H.
    Stepniewska, Kasia
    Sutanto, Inge
    Thwaites, Guy
    Hien, Tran T.
    White, Nicholas J.
    William, Timothy
    Woodrow, Charles J.
    Guerin, Philippe J.
    Price, Ric N.
    PLOS MEDICINE, 2019, 16 (10)
  • [42] Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
    Davlantes, Elizabeth
    Dimbu, Pedro Rafael
    Ferreira, Carolina Miguel
    Joao, Maria Florinda
    Pode, Dilunvuidi
    Felix, Jacinto
    Sanhangala, Edgar
    Andrade, Benjamin Nieto
    Souza, Samaly dos Santos
    Talundzic, Eldin
    Udhayakumar, Venkatachalam
    Owens, Chantelle
    Mbounga, Eliane
    Wiesner, Lubbe
    Halsey, Eric S.
    Martins, Jose Franco
    Fortes, Filomeno
    Plucinski, Mateusz M.
    MALARIA JOURNAL, 2018, 17
  • [43] A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
    Mens, P.
    Sawa, P.
    Omar, S.
    Kager, P.
    Schallig, H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 : S14 - S14
  • [44] A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
    Mens, P. F.
    Schallig, H.
    Sawa, P.
    Kager, P. A.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 : 44 - 44
  • [45] A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
    Mens, Petra F.
    Sawa, Patrick
    van Amsterdam, Sandra M.
    Versteeg, Inge
    Omar, Sabah A.
    Schallig, Henk D. F. H.
    Kager, Piet A.
    MALARIA JOURNAL, 2008, 7 (1)
  • [46] A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
    Petra F Mens
    Patrick Sawa
    Sandra M van Amsterdam
    Inge Versteeg
    Sabah A Omar
    Henk DFH Schallig
    Piet A Kager
    Malaria Journal, 7
  • [47] Asymptomatic recrudescence after artemether-lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis
    Mumtaz, Rida
    Okell, Lucy C.
    Challenger, Joseph D.
    MALARIA JOURNAL, 2020, 19 (01)
  • [48] Dihydroartemisinin-piperaquine versus artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysis
    Tozan, Y.
    Pfeil, J.
    Borrmann, S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 70 - 70
  • [49] Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
    Chris Ebong
    Asadu Sserwanga
    Jane Frances Namuganga
    James Kapisi
    Arthur Mpimbaza
    Samuel Gonahasa
    Victor Asua
    Sam Gudoi
    Ruth Kigozi
    James Tibenderana
    John Bosco Bwanika
    Agaba Bosco
    Denis Rubahika
    Daniel Kyabayinze
    Jimmy Opigo
    Damian Rutazana
    Gloria Sebikaari
    Kassahun Belay
    Mame Niang
    Eric S. Halsey
    Leah F. Moriarty
    Naomi W. Lucchi
    Samaly S. Svigel Souza
    Sam L. Nsobya
    Moses R. Kamya
    Adoke Yeka
    Malaria Journal, 20
  • [50] Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial
    Uwimana, Aline
    Penkunas, Michael J.
    Nisingizwe, Marie Paul
    Warsame, Marian
    Umulisa, Noella
    Uyizeye, Didier
    Musanabaganwa, Clarisse
    Munyaneza, Tharcisse
    Ntagwabira, Edouard
    Hakizimana, Dieudonne
    Muvunyi, Claude Mambo
    Kayobotsi, Claver
    Kabera, Michee
    Murindahabi, Monique
    Mbituyumuremyi, Aimable
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 (06) : 312 - 319